94
Views
25
CrossRef citations to date
0
Altmetric
Article

Cardioprotection with resveratrol pretreatment: improved beneficial effects over standard treatment in rat hearts after global ischemia

, , , , , , , & show all
Pages 245-254 | Received 21 Feb 2004, Accepted 06 Apr 2004, Published online: 12 Jul 2009

References

  • Hearse DJ. Myocardial ischemia: Can we agree on a definition for the 21st century? Cardiovasc Res 1994; 28(12): 1737–1744.
  • Zimmerman AN, Hulsmann WC. Paradoxical influence of calcium ions on the permeability of the cell membranes in the isolated rat heart. Nature 1966; 211: 646–647.
  • Hearse DJ, Humphrey SM, Bullock GR. The oxygen paradox and the calcium paradox: Two facets of the same problem? J Mol Cell Cardio 1978; 10(7): 641–668.
  • Hearse DJ, Humphrey SM, Nayler WG, Slade A, Border a Ultrastructural damage associated with reoxygenation of the anoxic myocardium. J Mol Cell Cardio 1975; 7: 315–324.
  • Renaud SC, Gueguen R, Schenker J, d'Houtaud A. Alcohol and mortality in middle-aged men from eastern France. Epidemiology 1998; 9: 184–188.
  • Law M, Wald N. Why heart disease mortality is low in France: The time lag explanation. Br Med J 1999 May 29; 318(7196): 1471–1476.
  • Kopp P. Resveratrol, a phytoestrogen found in red wine. A possible expla-nation for the conundrum of the "French Paradox". Eur J Endocrinol 1998; 138: 619–620.
  • Bertelli AA, Giovarmini L, Giannessi D, et al. Antiplatelet activity of synthetic and natural resveratrol in red wine. Int J Tissue React 1995; 17: 1–3.
  • Frankel EN, Waterhouse AL, Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet 1993; 341: 1103–1104.
  • Sun AY, Chen YM, James-Kracke M, Wixom P. Cheng Y. Ethanol-induced cell death by lipid peroxidation in PC12 cells. Neurochem Res 1997; 22: 1187–1192.
  • Maulik N, Engelman DT, Watanabe M, et al. Nitric oxide signaling in ischemic heart. Cardiovasc Res 1995; 30: 593–60L
  • Ray PS, Maulik G, Cordis GA, Bertelli AA, Bertelli A, Das DK. The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Radic Biol Med 1999; 27: 160–169.
  • Floreani M, Napoli E, Quintieri L, Palatini P. Oral administration of trans-resveratrol to guinea pigs increases cardiac DT-diaphorase and catalase activities, and protects isolated atria from menadione toxicity. Life Sci 2003; 72: 2741–2750. Scand Cardiovasc J 38
  • Asha S, Radha E Effect of age and myocardial infarction on serum and heart lactic dehydrogenase. Exp Gerontol 1985; 20(1): 67–70.
  • Gerhardt W, Ljungdahl L, Herbert AK. Troponin T and CK-MB (mass) in early diagnosis of ischemic myocardial injury. Clin Biochem 1993; 26(4): 231–240.
  • Bertinchant JP, Lame C, Pernel I, et al. Release kinetics of serum cardiac troponin I in ischemic myocardial injury. Clin Biochem 1996; 29(6): 587–594.
  • Bhayana V, Henderson AR. Biochemical markers of myocardial damage. Clin Biochem 1995; 28: 1–29.
  • Beutler E. The glutathione instability of drug sensitive red cells; A new method for the in vitro detection of drug sensitivity. J Lab Clin Med 1957; 49: 84–95.
  • Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxidase in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351–358.
  • Levine RL, Garland D, Oliver CN, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990; 186: 464–478.
  • Kaul N, Siveski-Iliskovic N, Hill M, Slezak J, Singal PK. Free radicals and the heart J Pharmacol Toxicol Methods 1993; 30: 55–67.
  • Zweier JL. Measurement of superoxide-derived free radicals in the reperfused heart: Evidence for a free radical mechanism of reperfusion injury. J Biol Chem 1988; 263: 1353–1357.
  • Das DK, Engelmann RM, Rousou JA, Breyer RH, Otani H, Lemeshow S. Pathophysiology of superoxide radicals as potential mediator of reperfusion injury in pig heart. Basic Res Cardiol 1986; 81: 155–166.
  • Robicsek F, Schaper J. Reperfusion injury: Fact or myth? J Cardiac Surg 1997; 12: 133–137.
  • Das DK, Maulik N. Antioxidant effectiveness in ischemia-reperfusion tissue injury. Methods Enzymol 1994; 233: 601–610.
  • Singal PK, Khaper N, Palace V, Kumar a The role of oxidative stress in the genesis of heart disease. Cardiovasc Res 1998; 40: 426–432.
  • Axford-Gatley RA, Wilson GJ. Reduction of experimental myocardial infarct size by oral administration of alpha tocopherol. Cardivasc Res 1991; 25: 89–92.
  • Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willet WC. Vitamin E consumption and risk of coronary disease in women. N Engl J Med 1993; 328: 1444–1449.
  • Hain R, Bieseler B, Kindl H, Schroder G, Stocker R. Expression of a stilbene synthase gene in Nicotiana tabacum results in synthesis of the phytolaxin resveratrol. Plant Mol Biol 1990; 2: 325–335.
  • Hung LM, Chen JK, Huang SS, Lee RS, Su MJ. Cardioprotective effect of resveratrol, a natural antioxidant derived from grape. Cardiovasc Res 2000; 47(3): 549–555.
  • Sinha K, Chaudhary G, Gupta YK. Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci 2002; 71(6): 655–665.
  • Imamura G, Bertelli AA, Bertelli A, Otani H, Maulik N, Das DK. Pharmacological preconditioning with resveratrol: An insight with iNOS knockout mice. Am J Physiol Heart Circ Physiol 2002 Jun; 282(6): 1996–2003.
  • Bertelli AA, Giovannini L, Stradi R, Urien S, Tillement JP, Bertelli A. Kinetics of trans- and cis-resveratrol after red wine oral administration in rats. Int J Clin Pharmacol Res 1996; 16: 77–81.
  • Bertelli A, Bertelli AA, Gozzini A, Giovannini L. Plasma and tissue resveratrol concentrations and pharmacological activity. Drug Exp Clin Res 1998; 24: 133–138.
  • Bradamante S, Piccinini F, Barenghi L, et al. Does resveratrol induce pharmacological preconditioning? Int J Tissue React 2000; 22(1): 1–4.
  • Blardi P. De Lalla A, Volpi L, Di Perri T. Stimulation of endogenous adenosine release by oral administration of quercetin and resveratrol in man. Drugs Exp Clin Res 1999; 25: 105–110.
  • Qiu Y, Rizvi A, Tand XL, et al. Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits. Am J Physiol 1997; 273: 2931–2936.
  • Fitzpatrick DF, Hirschfield SL, Coffey RG. Endothelium-dependent vaso-relaxing activity of wine and other grape products. Am J Physiol 1993; 265: 774–778.
  • Weiss HR, Rodriguez E, Tse J, Scholz PM. Effect of increased myocardial cyclic GMP induced by cyclic GMP-phosphodiesterase inhibition on oxygen consumption and supply of rabbit hearts. Clin Exp Pharmacol Physiol 1994; 21: 607–614.
  • Chen CK, Pace-Asciak CR. Vasorelaxing activity of resveratrol and quercetin in isolate rat aorta Gen Pharmacol 1996; 27: 363–366.
  • Hung LM, Su MJ, Chu WK, Chiao CW, Chan WF, Chen JK. The protective effect of resveratrol on ischemia-reperfusion injuries of rat hearts is correlated with antioxidant efficacy. Br J Pharmacol 2002 Apr; 135(7): 1627–1633.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.